Showing results (111-120 of 154) with videos related to
Sort By:
Pageof 16
Urology|January 17, 2022
Evaluation of the Influence of a History of Childhood Nocturnal Enuresis on Nighttime Urinary Frequency and the Causes of Nocturia in AdultsMinoru Miyazato, Munehisa Gakiya, Asuka Ashikari, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 24, 2023
Agile 3+ and Agile 4, noninvasive tests for liver fibrosis, are excellent formulae to predict liver-related events in nonalcoholic fatty liver diseaseKouichi Miura, Hideki Hayashi, Yoshihiro Kamada, et al.Biomedicine Hub|January 16, 2023
Effects of Low-Dose Colchicine on Serum High-Sensitivity C-Reactive Protein Level in Coronary Artery Disease Patients with Type 2 Diabetes Mellitus and Enhanced Inflammatory Response Protocol for a Randomized, Double-Blind, Placebo-Controlled, Phase 2, Dose-Finding StudyYoshikazu Miwa, Akiko Mutoh, Takeshi Morimoto, et al.Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|May 13, 2023
Effect of Nonsupplemented Low-Protein Diet on the Initiation of Renal Replacement Therapy in Stage 4 and 5 Chronic Kidney Disease: A Retrospective Multicenter Cohort Study in JapanHaruhisa Otani, Tadashi Okada, Yasushi Saika, et al.Cardiovascular Diabetology|September 15, 2016
Long-term effect of sitagliptin on endothelial function in type 2 diabetes: a sub-analysis of the PROLOGUE studyTatsuya Maruhashi, Yukihito Higashi, Yasuki Kihara, et al.Journal of Diabetes Investigation|May 22, 2026
Dapagliflozin does not impair microvascular hemorheology in type 2 diabetes mellitus: A multicenter randomized controlled trial (D-PATH study)Yuki Nakatani, Nobuyuki Banba, Shoya Ono, et al.Journal of Diabetes Investigation|June 16, 2020
Secondary analyses to assess the profound effects of empagliflozin on endothelial function in patients with type 2 diabetes and established cardiovascular diseases: The placebo-controlled double-blind randomized effect of empagliflozin on endothelial function in cardiovascular high risk diabetes mellitus: Multi-center placebo-controlled double-blind randomized trialAtsushi Tanaka, Michio Shimabukuro, Noritaka Machii, et al.Cardiovascular Diabetology|April 6, 2016
Rationale and design of a randomized trial to test the safety and non-inferiority of canagliflozin in patients with diabetes with chronic heart failure: the CANDLE trialAtsushi Tanaka, Teruo Inoue, Masafumi Kitakaze, et al.Cardiovascular Diabetology|June 19, 2016
Rationale and design of a multicenter randomized study for evaluating vascular function under uric acid control using the xanthine oxidase inhibitor, febuxostat: the PRIZE studyJun-Ichi Oyama, Atsushi Tanaka, Yasunori Sato, et al.International Heart Journal|July 14, 2012
A multicenter study design to assess the clinical usefulness of semi-automatic measurement of flow-mediated vasodilatation of the brachial arteryHirofumi Tomiyama, Takahide Kohro, Yukihito Higashi, et al.Pageof 16